These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2425102)

  • 1. The role of renal kallikrein and prostaglandin in the control of renin release.
    Suzuki S; Kobayashi M; Hashiba K
    Jpn Heart J; 1986 Jan; 27(1):83-93. PubMed ID: 2425102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of renal kallikrein in control of renin release in conscious rats.
    Kobayashi M; Suzuki S; Hashiba K
    Am J Physiol; 1983 Mar; 244(3):E262-5. PubMed ID: 6187220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrelationships between the renal kallikrein-kinin and prostaglandin systems in furosemide-induced diuresis.
    Ayano Y; Yamasaki K; Soejima H; Ikegami K
    Urol Int; 1984; 39(1):52-7. PubMed ID: 6587655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal kallikrein-kinin: its relation to renal prostaglandins and renin-angiotensin-aldosterone in man.
    Abe K; Sato M; Imai Y; Haruyama T; Sato K; Hiwatari M; Kasai Y; Yoshinaga K
    Kidney Int; 1981 Jun; 19(6):869-80. PubMed ID: 7021957
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of aprotinin (a serine protease inhibitor) on renal function and renin release.
    Seto S; Kher V; Scicli AG; Beierwaltes WH; Carretero OA
    Hypertension; 1983; 5(6):893-9. PubMed ID: 6197374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergic effects of kallikrein-kinin and prostaglandins on renin release on infusion of isolated hog kidney with aldosterone.
    Gotoh S; Ogihara T; Nakamaru M; Ohde H; Higaki J; Otsuka A; Tabuchi Y; Kumahara Y; Nishino T
    Life Sci; 1984 May; 34(20):1913-8. PubMed ID: 6203005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prostaglandin synthesis inhibitors on the renin-angiotensin system and renal function.
    Izumi Y; Franco-Saenz R; Mulrow PJ
    Hypertension; 1985; 7(5):791-6. PubMed ID: 3861577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of the prostaglandin system in furosemide-induced changes of renal function in anesthetized rats.
    Yoshida M; Suzuki-Kusaba M; Satoh S
    Ren Physiol; 1987; 10(1):25-32. PubMed ID: 2446364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of diuretics with the renal kallikrein-kinin and prostaglandin systems.
    Overlack A; Stumpe KO; Müller HM; Kolloch R; Higuchi M
    Klin Wochenschr; 1982 Oct; 60(19):1223-8. PubMed ID: 6183482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of indomethacin on plasma renin activity in the conscious rat.
    Suzuki S; Franco-Saenz R; Tan SY; Mulrow PJ
    Am J Physiol; 1981 Mar; 240(3):E286-9. PubMed ID: 7011052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid escape during kallikrein inhibition.
    Overlack A; Bäcker-Kreutz E; Ressel C; Müller HM; Kolloch R; Stumpe KO
    Clin Sci (Lond); 1986 Jan; 70(1):13-7. PubMed ID: 2417776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Furosemide interaction with the prostaglandin and kallikrein-kinin systems of the kidneys].
    Kuz'min OB; Mikhaĭlenko PV; Kriukova RA
    Farmakol Toksikol; 1986; 49(2):21-4. PubMed ID: 2423364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of plasma renin activity by indomethacin in man.
    Frölich JC; Hollifield JW; Dormois JC; Frölich BL; Seyberth H; Michelakis AM; Oates JA
    Circ Res; 1976 Sep; 39(3):447-52. PubMed ID: 821675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of aprotinin, a kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Bandiera F; Manunta P; Rubattu S; Rappelli A
    J Hypertens; 1987 Oct; 5(5):581-6. PubMed ID: 2448367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of renal prostaglandin E and kallikrein in pathogenesis of essential hypertension.
    Abe K; Yasujima M; Sakurai Y; Chiba S; Itoh T; Imai Y; Sato M; Haruyama T; Omata K; Goto T; Sato K; Hiwatari M; Otsuka Y; Yoshinaga K
    Jpn Circ J; 1979 Dec; 43(12):1105-16. PubMed ID: 396385
    [No Abstract]   [Full Text] [Related]  

  • 17. Interrelations of the renal kallikrein-kinin system and renal prostaglandins in the conscious rat. Influence of mineralocorticoids.
    Nasjletti A; McGiff JC; Colina-Chourio J
    Circ Res; 1978 Nov; 43(5):799-807. PubMed ID: 309362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of prostaglandin inhibition on renin release. A comparison of furosemide and low-sodium stimulation tests.
    Goldiner WH; Valente WA; Hamilton BP; Mersey JH
    J Lab Clin Med; 1981 Dec; 98(6):929-37. PubMed ID: 7031155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between kallikrein and PRA after intravenous furosemide.
    Cinotti GA; Stirati G; Taggi F; Ronci R; Simonetti BM; Pierucci A
    J Endocrinol Invest; 1979; 2(2):147-50. PubMed ID: 489923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated hypoaldosteronism and abnormalities in renin, kallikrein, and prostaglandin.
    Kaufman JS; Peck M; Hamburger RJ; Flamenbaum W
    Nephron; 1986; 43(3):203-10. PubMed ID: 3523269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.